Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05310058 · ClinicalTrials.gov registry record · NA
Pharmacokinetics of C6 Ketone Di-ester
A NA study, sponsored by BHB Therapeutics, Ireland.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05310058 is a NA study that has completed, run by BHB Therapeutics, Ireland. The registered enrollment target is 34 participants.
The verdict
NCT05310058, a NA study, has completed, sponsored by BHB Therapeutics, Ireland.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Randomized, parallel repeat dose pharmacokinetic study of C6 ketone di-ester in a ready to drink beverage matrix.
Interventions
- DIETARY_SUPPLEMENT C6 ketone di-ester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-04-11 |
| Est. Completion | 2022-08-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05310058
The ClinicalTrials.gov registry entry for NCT05310058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BHB Therapeutics, Ireland, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which C6 ketone di-ester is the first listed.
NCT05310058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05310058 about?
NCT05310058 is a clinical study titled "Pharmacokinetics of C6 Ketone Di-ester". Randomized, parallel repeat dose pharmacokinetic study of C6 ketone di-ester in a ready to drink beverage matrix.
What is the current status of trial NCT05310058?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2022-04-11. Estimated completion is 2022-08-23.
What interventions are being tested in trial NCT05310058?
The interventions under investigation include: C6 ketone di-ester (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05310058?
This trial is sponsored by BHB Therapeutics, Ireland, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.